Literature DB >> 653578

Ophthalmic ointments.

J S Robin, P P Ellis.   

Abstract

The use of ointments as an ocular drug vehicle adds an important dimension to topical therapy. Ointments are well tolerated, fairly safe, and provide an excellent means for enhanced ocular contact time. In the case of certain antibiotics, this improved contact time yields increased ocular drug levels. However, experimental data indicate that corticosteroid ointments do not penetrate into the eye as well as do suspension preparations. This may relate to the binding of the drug to the ointment base and also to the particular steroid compound. Like other ophthalmic preparations, ointments may become contaminated. Ophthalmic ointments should not be instilled into eyes with open wounds. Instillation of ointments into postoperative eyes where wound closure is secure appears to be safe and effective.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 653578     DOI: 10.1016/0039-6257(78)90178-9

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  5 in total

1.  Erythromycin bioactivity is stable in ophthalmic ointment used for prophylaxis of neonatal gonococcal conjunctivitis.

Authors:  M G Bialer; E J Baron; R G Harper
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

Review 2.  Treatment of ocular infections with topical antibacterials.

Authors:  J P Leeming
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

3.  Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study.

Authors:  Dorothy S P Fan; Dennis S C Lam; Carmen K M Chan; Alex H Fan; Eva Y Y Cheung; Srinivas K Rao
Journal:  Jpn J Ophthalmol       Date:  2007-02-09       Impact factor: 2.447

Review 4.  Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents.

Authors:  Eliana B Souto; João Dias-Ferreira; Ana López-Machado; Miren Ettcheto; Amanda Cano; Antonio Camins Espuny; Marta Espina; Maria Luisa Garcia; Elena Sánchez-López
Journal:  Pharmaceutics       Date:  2019-09-06       Impact factor: 6.321

5.  Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations.

Authors:  Maxime Le Merdy; Jessica Spires; Viera Lukacova; Ming-Liang Tan; Andrew Babiskin; Xiaoming Xu; Liang Zhao; Michael B Bolger
Journal:  Pharm Res       Date:  2020-11-19       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.